We describe a pregnant woman with systemic lupus erythematosus, complicated by severe pre-eclampsia (the HELLP syndrome) and adult respiratory distress syndrome, who died in the intensive care unit.
Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease of unknown cause, involving connective tissue and characterized by the production of multiple autoantibodies. It occurs most frequently in young women, whose fertility rate remains unaffected 1 . The impact of pregnancy on lupus disease remains controversial. Studies have demonstrated that exacerbations or "flares" of SLE may increase 2 , decrease or remain unchanged throughout pregnancy 3, 4 .
Pre-eclampsia, a syndrome unique to human pregnancy, featuring hypertension and proteinuria, occurs after 20 weeks' gestation or earlier in disorders such as trophoblastic disease or SLE 5 . Pregnant women with SLE are at an increased risk of maternal complications, including pre-eclampsia and the HELLP (haemolysis, elevated liver enzymes, and low platelet count) syndrome 6 . The latter is a variant of preeclampsia associated with a higher rate of maternal and fetal morbidity and mortality 7 . There are potential associations between SLE, pre-eclampsia, lupus nephritis, antiphospholipid syndrome, thrombotic thrombocytopenic purpura, haemolytic uraemic syndrome, disseminated intravascular coagulopathy and acute fatty liver of pregnacy. It is not always possible to make the distinction between active lupus and other disorders and occasionally more than one occurs concurrently. However, it is important for treatment decisions to attempt to distinguish between them 7, 8 .
This report describes a pregnant woman with SLE, complicated by the HELLP syndrome and acute respiratory distress syndrome (ARDS), who died in the intensive care unit (ICU).
CASE HISTORY
A 33-year-old gravida 3, para 2 woman, with SLE of six years' duration and previously in remission, was sent to the state hospital complaining of severe joint pain, lassitude, malaise and facial rash. An unplanned pregnancy of 17 weeks gestation and an exacerbation of SLE, including elevated liver enzymes and thrombocytopenia (platelet count 90x 10 9 /l) were diagnosed. After receiving intravenous (IV) prednisolone 40 mg, low dose aspirin 80 mg and a one-unit platelet transfusion, she was referred to our university hospital. The initial treatment of SLE had included oral methylprednisolone 1 mg/kg/day for three weeks. This had been tapered progressively to maintain a clinical remission and hydroxychloroquine sulphate 200 mg daily continued because of the presence of mild polyarthritis and malar rash. She had had an uneventful anaesthetic for tonsillectomy in 1982.
At the time of admission to our hospital, on physical examination she had a butterfly rash over the cheeks, purpura, acute synovitis and oedema of the legs. Her temperature was 37°C, blood pressure (BP) 180/100 mmHg and pulse rate 130 beats/min. The electrocardiogram and chest X-ray were unremarkable. No abnormalities were seen on ultrasound examination and fetal growth corresponded with gestational age.
In addition to the initial laboratory tests (Table  1) , other results included red blood cell count 3,450,000/mm 3 , erythrocyte sedimentation rate 20/ 40 mm, international normalized ratio (INR) 1.01; proteinuria +3 (dipstick), 24 hour urine collection creatinine clearance 85 ml/min and total protein 9 g. A peripheral blood smear showed haemolysis. Immunological evaluation was performed for antibodies to extractable nuclear antigens, including anti-Ro (SSA): 4 EU/ml, anti-La (SSB): 4 EU/ml. Lupus anticoagulant screening was negative, anticardiolipin antibody titre was <22 GPL units, and antinuclear antibodies were positive at 1:320, antidoublestranded DNA antibodies were 78 IU. Complement C 3 and C 4 were low (84 mg/dl and 21 mg/dl respectively) and Coombs' test was 3+ positive for autoimmune haemolysis.
The patient was hospitalized in the Department of Haematology with a diagnosis of active SLE complicated by HELLP syndrome, based on the following criteria: acute synovitis and skin lesions, thrombocytopenia <90x10 9 /l, Coombs' positive haemolytic anaemia, active renal disease and low serum complement levels. The diagnosis of HELLP syndrome 8 ( Table 1 ) was based on a BP of 200/120 mmHg, ALT and AST >70 IU/l, proteinuria, thrombocytopenia and total bilirubin concentration of 8.3 mg/dl. She received propranolol and prednisolone 250 mg IV.
The week following admission was uneventful. The triple test was normal and ultrasonography and echocardiography were planned for 18 weeks' gestation. However, at this time she suddenly became confused and convulsed (eclampsia). Her BP was 180/ 100 mmHg, Glascow Coma Score (GCS) 10 (3+3+4) and she was spontaneously breathing. Her pupils showed isocoria and equal positive pupillary light reflexes. Fundoscopy demonstrated early, mild papilloedema with a normal macula and no exudates. Following neurological consultation, computerized tomography (CT) of the brain was proposed, but imaging was not performed because her general condition worsened. She was transferred to the Obstetric Department where magnesium sulphate (4 g IV then 1 g/h infusion) was administered and prostaglandininduced therapeutic abortion was induced. Her laboratory results had deteriorated ( Table 2) . A central venous catheter was placed and her magnesium sulphate infusion was discontinued after she aborted, because she had become oliguric. She received nephramine, dopamine and ceftriaxone, was transfused with two units of packed red blood cells, 15 ml/ kg of fresh frozen plasma, 1 unit of platelets and 1 unit of 4% human albumin 100 ml. Prednisolone 80 mg IV was continued for two days.
She was then transferred to the ICU in respiratory failure, probably due to ARDS. Her APACHE (Acute Physiology, Age, Chronic Health Evaluation) II score was 17 and neurological examination demonstrated a GCS of 14 (4+6+4). Her arterial blood gas analysis showed pH 7.42, P a CO 2 20 mmHg, and P a O 2 68 mmHg. A CT scan of the head showed no abnormality. She required oxygen therapy, glyceryl trinitrate infusion to control hypertension and red cell, platelet and fresh frozen plasma transfusions. After 2,550 ml of IV crystalloid her 24 h urinary output was 280 ml and central venous pressure (CVP) 11 cmH 2 O.
During the third day in ICU her general condition worsened, with deterioration of her acid-base status (pH 7.41, P a O 2 48 mmHg, P a CO 2 30 mmHg, TABLE 1 The criteria for diagnosis of the HELLP syndrome 8
Haemolysis
Abnormal peripheral blood smear Increased lactic dehydrogenase (>600 IU/l) Increased total bilirubin (>1.2 mg/dl) Elevated liver enzymes (increased AST >70 U/l) Low platelets (platelet count <100x10 9 /l) HCO 3 -19 mM/l, P a O 2 /fraction of inspired oxygen (FiO 2 ) ratio <200 mmHg). She was intubated and ventilated using synchronous intermittent mandatory ventilation (SIMV) mode, with a positive end-expiratory pressure (PEEP) of 5 cmH 2 O, maintaining endinspiratory plateau pressure of less than 35 cmH 2 O. The initial FIO 2 was 50% and tidal volume 6 ml/kg, with ventilator parameters regulated according to lung protective ventilation strategies. Clindamycin was added to ceftriaxone and a sodium nitroprusside infusion initiated at 1 ml/h because of resistance to glyceryl trinitrate. She remained severely oliguric (30 ml per 24 hours).
On the sixth ICU day a right basal lung infiltrate was suspected. Cultures were taken of blood (negative), tracheal aspirate (positive for Enterobacter cloacae) and urine (negative). Sulbactam/cefoperazon and amikacin were commenced. Her acid-base status (pH 7.4, P a O 2 81 mmHg, P a CO 2 27 mmHg) and laboratory results improved. Prednisolone 80 mg/ day was continued and in view of her CVP rising to 22 cmH 2 O and serum creatinine further increasing, dialysis was instituted for two consecutive days from the eighth day. On days 9 through 11 she remained hypertensive and febrile (38.2 °C). Her thyroid stimulating hormone level was 0.07 mU/l, freeT 3 3.42 and freeT 4 1.51. She remained in acute renal failure and on day 14 a tracheostomy was performed. Chest X-ray demonstrated left lung infiltration without evidence of left atrial hypertension or congestive heart failure. In total she received over 20 units of red blood cells and large quantities of fresh frozen plasma and platelets. On the 24th day her GCS was 2 (1+1+E) and severe hypotension developed. Despite further medical therapy, she died from worsening ARDS on the 25th day. A post mortem was refused by her family.
DISCUSSION
Differences in the definition of acute lupus flare make it difficult to determine the risk of an exacerbation of SLE during pregnancy. Many complications common to pregnancy may be mistakenly attributed to SLE 3, 4 . Recent prospective studies 3, 9 do not indicate increased fetal and maternal risk with SLE, which contrasts with earlier studies [10] [11] [12] .
A "lupus flare" comprising proteinuria, thrombocytopenia, hypertension, and electrolyte disturbance can lead to diagnostic confusion with preeclampsia 13, 14 . While distinguishing between these can be important for treatment, sometimes a definite diagnosis cannot be made or the conditions coexist. Pre-eclampsia frequently leads to early delivery and, especially when remote from term, can result in sig-nificant neonatal morbidity and mortality. Systemic lupus can be treated with a variety of drugs. Our patient had a history and clinical features (such as arthritis, proteinuria without red or white blood cells and cellular casts and positive antinuclear factor) that helped distinguish between an exacerbation of SLE and severe pre-eclampsia. Generally, low complement levels and high titres of anti-DNA and anti-C1q antibodies are frequently associated with active SLE with or without renal lupus, while these parameters are usually normal in pre-eclampsia and in normal pregnancy 15 . Thrombocytopenia, elevated serum levels of liver enzymes and uric acid are more prominent in pre-eclampsia. In addition, after delivery proteinuria rapidly decreases in pre-eclampsia, but tends to persist or increase in SLE. In difficult cases a renal biopsy can provide an accurate diagnosis and lead to appropriate therapy for renal lupus (Table 3) 16, 17 .
In general, pregnancy does not affect the course of SLE and thus therapeutic abortion is rarely indicated. However, pregnancy in the presence of active nephritis has a worse prognosis. Poor fetal outcome and immunological events are closely associated with lupus nephritis. The pregnancy outcome is better if certain preconditions have been met 13 , such as prepregnancy remission of at least six months, and adequate renal function (serum creatinine 1.5 mg/ dl; creatinine clearance ≤ 60 ml/min; proteinuria= 3 g/day).
Maternal mortality in HELLP syndrome can be due to intracranial or hepatic haemorrhage and disseminated intravascular coagulopathy 7 . Termination of pregnancy is the only definitive therapy and may be indicated in women of less than 24 weeks' gestation refractory to bed rest and medical therapy, in whom the maternal or fetal condition rapidly deteriorates or who suffer severe thrombocytopenia with elevated fibrin degradation products or severe thrombotic microangiopathy 7, 12 . Management requires a team approach with an obstetrician, nephrologist, rheumatologist, neonatologist and anaesthetist working in collaboration 18 . In this case, therapeutic abortion was indicated for deteriorating maternal organ function unresponsive to therapy.
It may be difficult to differentiate an exacerbation of SLE from pregnancy-associated thrombotic microangiopathy. The presence of microangiopathic haemolytic anaemia, thrombocytopenia and renal failure suggests the haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura is characterized by the classic pentad of thrombocytopenia, Coombs' negative microangiopathic haemolytic anaemia, fluctuating neurological signs, renal impairment and fever 7, 19 . Haemolytic uraemic syndrome is 20, 21 and when associated with pregnancy, typically presents post partum 22 . A history of a viral or bacterial gastrointestinal illness with toxin-producing organisms, especially with diarrhoea, is common in haemolytic uraemic syndrome 20, 21 . The platelet microthrombi are primarily confined to the kidneys, and thus renal failure is the dominant feature in haemolytic uraemic syndrome with or without pre-existing renal disease, whereas haemolytic uraemic syndrome usually develops after normotensive pregnancy with uncomplicated delivery 7, 12 . Thrombotic thrombocytopenic purpura usually develops relatively early in pregnancy, while most cases of pre-eclampsia and HELLP develop in the third trimester 7, 20 . Multiparity is an association with the HELLP syndrome 20, 21 . Fever, if present, is moderate in thrombotic thrombocytopenic syndrome and haemolytic uraemic syndrome, but rare in HELLP 20, 21 . Neurological manifestations are usual in thrombotic thrombocytopenic syndrome and also frequently in the HELLP syndrome 19 and both are often characterized by severe thrombocytopenia, which may be useful in its differentiation from haemolytic uraemic syndrome 19 . In contrast to HELLP syndrome, coagulation studies are usually normal in thrombotic thrombocytopenic purpura, with only mildly raised D-dimer levels 19 . Patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome generally maintain normal levels of antithrombin, while most of those with HELLP display modest reductions in antithrombin levels, likely due to consumption 20 (Table 3 ). In our patient, platelet counts and antithrobin III levels were decreased and hepatic transaminases and lactic dehydrogenase were increased before delivery. The progressive increase in platelet count after delivery, accompanied by a decrease in serum hepatic transferase level and in lactic dehydrogenase and normalization of coagulation tests, all indicated an exacerbation of SLE complicated by HELLP syndrome in the ante-partum period.
To improve maternal and fetal survival, pregnant women with SLE should be advised to become pregnant only when the disease is inactive and should be observed at a centre that has experience dealing with these serious complications, with joint management using a multidisciplinary approach. Therapeutic abortion is an acceptable option if active nephropathy and HELLP syndrome are present in earlier pregnancy.
